期刊文献+

潜阳解毒通络饮通过PPAR-γ途径抑制炎症因子表达从而对自发性高血压大鼠炎症机制干预的研究 被引量:3

Qianyang Jiedu Tongluo Decoction on inflammatory intervention mechanism in spontaneously hypertensive rats expression by acting on PPAR-γ pathway inhibition of inflammatory factors
下载PDF
导出
摘要 目的探讨潜阳解毒通络饮治疗原发性高血压大鼠的作用机制。方法选择健康雄性12周龄原发性高血压大鼠(spontaneously hypertensive rats,SHR)71只,随机分为潜阳组、解毒组、通络组、全方组、缬沙坦组、吡格列酮组、SHR空白对照组,魏-凯二氏大鼠(Wistar-Kyoto rats,WKY)大鼠10只作为正常血压对照组。给药2个月后处死取腹主动脉血和心脏左心室。用ELISA试剂盒测血清中超敏C反应蛋白(high-sensitivity c-reactive protein,hs-CRP)、肿瘤坏死因子(tumor necrosis factor-a,TNF-a)、白介素1β(interleukin-lβ,IL-1β)的浓度。聚合酶链反应(polymerase chain reaction,PCR)测过氧化物酶体增殖物激活受体γ(peroxisome proliferators activated receptors,PPAR-γ)、果蝇受体4(toll-like receptor4,TLR4)及TNF-a的mRNA在大鼠心肌细胞中的表达。结果潜阳解毒通络饮能够有效抑制SHR血清中IL-1β、TNF-α及hs-CRP炎症因子的表达,有统计学意义(P<0.05)。在SHR心肌组织mRNA的表达上,TNF-a、TLR4及PPAR-γ的mRNA表达与其他治疗组和对照组相比有统计学意义(P<0.05)。结论证实了潜阳解毒通络饮从"风痰瘀络"病机的角度治疗原发性高血压大鼠有效性,其作用机制可能与作用于PPAR-γ途径、改善炎症因子表达有关。 Objective To investigate the mechanism of Qianyang Jiedu Tongluo Decoction for the treatment of hypertensive rats. Methods healthy male 12 weeks Lingyuan hypertension rat (SHR) 72, 10 WKY rats, randomly divided into Qianyang Group, detoxifieation group, Tongluo group, the whole Party group, valsartan group, SHR treatment group, blank control group and Control group. After 2 months of administration take blood from the abdominal aorta and the left ventricle of the heart. The concentration of serum hs-CRP, TNF-a, IL-1β ELISA kit. Expression of PPAR-γ, TNF-a and TLR4 RT-PCR mRNA in myocardial cells of rats. Results Qianyang Jiedu Tongluo Decoction can effectively inhibit the expression of SHR in rat serum IL-1β, TNF-α and hs-CRP inflammatory factors, with statistical significance ( P 〈 0. 05 ). The expression of mRNA in myocardial tissue of SHR rats on the TNF-α, TLR4, and PPAR-γ mRNA expression compared with other treatment group and the control group was statistically significant( P 〈0. 05 ). Conclusion the treatment of confirmed hypertensive rats from the "wind phlegm blood sta- sis collaterals" pathogenesis angle Qianyang Jiedu Tongluo Decoction is effective, its mechanism may be re- lated to effects on PPAR-γ way, improve the expression of inflammatory factors relat.
出处 《环球中医药》 CAS 2013年第6期407-412,共6页 Global Traditional Chinese Medicine
基金 吉林省科技厅:熄风解毒通络饮干预高血压心肌肥厚微炎症信号转导及机制研究资助(201115177)
关键词 高血压病 果蝇受体4 过氧化物酶体增殖物激活受体Γ 潜阳解毒通络饮 炎症因子 Hypertension TLR4 PPAR-γ Qianyang Jiedu Tongluo Decoction Inflamma-tory factor
  • 相关文献

参考文献12

  • 1BautistaLE, VeraLM, Arenas IA etal. Inde Pendentassoeiationbetween inflammatory markers ( C- Reactive Protein, interleukin-6,and TNF alpha) and essential hypertension [ J]. JHum Hyper-tens,2005 ,19(2) :149-151.
  • 2Parker LC,PrinceLR, Sabroel. TranslationalMinireviewseriesontoll-like receptors : networks regulatedby tolllikereceptors mediateinnate and adaptive immunity[ J]. Clin Exp Immunol,2007,147(2):199-207.
  • 3Akira S, Uematsu S, Takeuchi 0. Pathogen recognition and in-nateimmunity[J]. Cell, 2006,124(4):783-801.
  • 4张莉莉,李敬诚,王景周,谢鹏.PPAR-γ在高血压血管平滑肌细胞表型转化中的作用[J].第三军医大学学报,2009,31(4):311-314. 被引量:6
  • 5孙慧英,李涛.脑卒中及其危险因素分析[J].卒中与神经疾病,2012,19(3):167-170. 被引量:71
  • 6KimKI, LeeJH, Chang HJ, et al. Association between bloodpressure variability and inflammatory marker in hypertensive pa-tients[J]. Circulation, 2008, 72(2) : 293-298.
  • 7Edfeldt K, Swedenborg J, Hansson GK,et al. Expression of toll-like receptor in human atherosclerotic ledions : a possible pathwayfor plaque activation [ J]. Circulation, 2002, 105 ( 10 ):1158-1161.
  • 8Sheu JJ,Chang LT. Prognostic value of activated toll-like recepto-er4 in monocytes following acute myocardial infarction[ J],2007,154(3) :581-588.
  • 9Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-kap-paBsignaling in heart[ J]. J Mol Cell Cardiol,2006,41 (4) :580-591.
  • 10邓悦,常立萍,齐锋,李双娣,崔英子.高血压病从“风痰瘀络”论治的思考[J].中华中医药学刊,2011,29(4):750-751. 被引量:16

二级参考文献18

  • 1杨传华,韩玉水,刘政.中医药逆转高血压左心室肥厚的理论探讨[J].河北中医,1994,16(5):1-2. 被引量:25
  • 2张莉莉,祝之明,曹廷兵,王利娟.Blockage of PPARδ increases the expression of inflammatory factors in 3T3-L1 cells stimulated with TNFα[J].Journal of Medical Colleges of PLA(China),2006,21(2):77-81. 被引量:2
  • 3邓铁涛.高血压病辨证论治的体会.新中医,1980,(2):10-10.
  • 4吴江.神经病学.北京:人民卫生出版社,2007.7:214-217.
  • 5Inoue R, Ohkubo T, Kikuya M, et al. Stroke risk of blood pres- sure in Dices determined by home blood pressure measurement: the Ohasama study. Stroke, 2009,40 (8) : 2859-2861.
  • 6Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BJM, 1989,298(6676):789-794.
  • 7Goldstein LB, Adams R, Becker K, et al. Primary prevention of is- chemic stroke: Astatement forhealth care professionals from the Stroke Council of the American Heart Association. Circulation, 2001, 103(1 ) : 163-182.
  • 8Iso H, Jacobs DR, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350, 977 men screened for themultiple risk factor intervention trial. N Engl JMed, 1989,32(I (14) :904-910.
  • 9Prospective studies collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 pro- spective cohorts. Prospective studies collaboration. Lancet, 1995, 346(8991 ) :1647-1653.
  • 10Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein- cholesterol and risk of stroke and carotid atherosclerosis: A sys- tematic review. Atherosclerosis, 2008. 9 (6) : 489-496.

共引文献92

同被引文献42

引证文献3

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部